A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer

Immune checkpoint inhibitors (ICIs) have significantly improved overall survival (OS) in metastatic non-small cell lung cancer (m-NSCLC). However, not all patients with m-NSCLC benefit from ICIs, and resistance to ICIs is an emerging challenge. The tumour microenvironment (TME) is immunosuppressive,...

Descripción completa

Detalles Bibliográficos
Autores principales: Akanda, Zarique Z., Neeson, Paul J., John, Thomas, Barnett, Stephen, Hanna, Gerard G., Miller, Alistair, Jennens, Ross, Siva, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Lung Cancer and The Immune System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264312/
https://www.ncbi.nlm.nih.gov/pubmed/34295676
http://dx.doi.org/10.21037/tlcr-20-1117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264312/
https://www.ncbi.nlm.nih.gov/pubmed/34295676
http://dx.doi.org/10.21037/tlcr-20-1117

Ejemplares similares